Shares of IMAC Holdings, Inc. (NASDAQ:IMAC – Get Free Report) were up 7.7% during mid-day trading on Thursday . The company traded as high as $0.12 and last traded at $0.10. Approximately 5,438,363 shares were traded during trading, an increase of 668% from the average daily volume of 708,132 shares. The stock had previously closed at $0.10.
IMAC Trading Up 7.7 %
The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.01. The business has a fifty day moving average price of $0.11 and a 200 day moving average price of $0.14.
Hedge Funds Weigh In On IMAC
An institutional investor recently bought a new position in IMAC stock. Virtu Financial LLC purchased a new stake in IMAC Holdings, Inc. (NASDAQ:IMAC – Free Report) in the second quarter, according to its most recent filing with the SEC. The fund purchased 66,755 shares of the company’s stock, valued at approximately $55,000. Virtu Financial LLC owned about 0.25% of IMAC at the end of the most recent quarter. 24.27% of the stock is owned by institutional investors.
IMAC Holdings, Inc owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains.
- Five stocks we like better than IMAC
- What is the Death Cross and How Can Investors Use it For Successful Trading?
- These 3 Wood Stocks are about to go on Discount
- What to Know About Investing in Penny Stocks
- Same Coin, Different Sides: 2 Observability Stocks Reverse Ways
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Stocks Awaiting Winter Winds of Opportunity
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.